Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01642823 · ClinicalTrials.gov registry record
Cancer Biology of Retinoblastoma
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 8
- Enrollment target
NCT01642823: Clinical Trial study, sponsored by Stanford University.
NCT01642823 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01642823 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Many children with the childhood cancer, Retinoblastoma, have surgery to remove the tumor and sometimes the entire eye. The purpose of this study is to collect the extra tissue from patients who undergo tumor removal for laboratory experiments that will help us understand not only what occurs in retinoblastoma cells but also how cells normally function. Some of these studies will include an evaluation of how cells control the way that genes are expressed, how cells "know" to become retinal cells, how cells remain retinal cells, how cells lose their identity as retinal cells, what changes make retinoblastoma cells different from normal retinal cells, and what changes make some retinoblastomas worse than others.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01642823
The ClinicalTrials.gov registry entry for NCT01642823 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01642823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01642823 about?
NCT01642823 is a clinical study titled "Cancer Biology of Retinoblastoma". Many children with the childhood cancer, Retinoblastoma, have surgery to remove the tumor and sometimes the entire eye. The purpose of this study is to collect the extra tissue from patients who undergo tumor removal for laboratory experiments that will help us understand not only what occurs in ret...
What is the current status of trial NCT01642823?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2012-07. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01642823?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.